4
Changes in Ownership
Greenwich LifeSciences, Inc. Filed Acc 0001493152-25-001298
CEO and CFO bought 2,900 shares at an average $13.58 ($39,391)
From the SEC's structured data for this filing
Trades in this filing
Patel Snehal · CEO and CFO
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-01-06 | Purchase : show line 1 in the form | +1,100 | $13.31 | $14,641 | 5,548,202 | D |
| 2025-01-07 | Purchase : show line 2 in the form | +1,800 | $13.75 | $24,750 | 5,550,002 | D |
| Open-market purchases · 2,900 sh · avg $13.58 · $39,391 | ||||||
Loading xslF345X05/ownership.xml…